Lorantis
Cambridge
About Lorantis
Lorantis develops products for the selective treatment of immunological and inflammatory diseases. It develops therapeutics for immunological diseases, including allergy, asthma, autoimmune diseases, and transplant regulation. The company is based in Cambridge, United Kingdom.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $44.0M
- Funding stage: M&A
- Last round: Series C (Oct 2005)
- Website: lorantis.co.uk
- Phone: +44 012-2370-2500
Industries & Categories
Health Care, Health Diagnostics, Medical Device
Canonical: https://fsome.com/organization/lorantis-2148254 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.